持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/06/30 | 2,976 | 2,998 | 2,965 | 2,965 | +3 | +0.1% | 24,000 |
| 2025/06/27 | 2,965 | 2,995 | 2,949 | 2,962 | +12 | +0.4% | 37,200 |
| 2025/06/26 | 2,935 | 2,950 | 2,926 | 2,950 | +12 | +0.4% | 20,200 |
| 2025/06/25 | 2,930 | 2,943 | 2,916 | 2,938 | -8 | -0.3% | 16,300 |
| 2025/06/24 | 2,972 | 2,972 | 2,943 | 2,946 | +11 | +0.4% | 12,900 |
| 2025/06/23 | 2,938 | 2,956 | 2,924 | 2,935 | -7 | -0.2% | 16,100 |
| 2025/06/20 | 2,920 | 2,959 | 2,920 | 2,942 | ±0 | ±0% | 28,400 |
| 2025/06/19 | 2,933 | 2,946 | 2,918 | 2,942 | -3 | -0.1% | 14,600 |
| 2025/06/18 | 2,937 | 2,979 | 2,929 | 2,945 | +4 | +0.1% | 20,100 |
| 2025/06/17 | 2,958 | 2,962 | 2,934 | 2,941 | -16 | -0.5% | 21,400 |
| 2025/06/16 | 2,974 | 2,974 | 2,951 | 2,957 | +12 | +0.4% | 8,800 |
| 2025/06/13 | 2,956 | 2,961 | 2,929 | 2,945 | -25 | -0.8% | 31,400 |
| 2025/06/12 | 2,985 | 3,005 | 2,958 | 2,970 | -40 | -1.3% | 17,600 |
| 2025/06/11 | 2,987 | 3,030 | 2,987 | 3,010 | +23 | +0.8% | 16,400 |
| 2025/06/10 | 2,985 | 3,035 | 2,980 | 2,987 | +10 | +0.3% | 24,700 |
| 2025/06/09 | 2,990 | 2,992 | 2,955 | 2,977 | +10 | +0.3% | 14,600 |
| 2025/06/06 | 2,955 | 2,985 | 2,955 | 2,967 | +12 | +0.4% | 14,100 |
| 2025/06/05 | 2,932 | 2,957 | 2,929 | 2,955 | +6 | +0.2% | 18,100 |
| 2025/06/04 | 2,938 | 2,979 | 2,938 | 2,949 | +11 | +0.4% | 15,600 |
| 2025/06/03 | 2,964 | 2,964 | 2,932 | 2,938 | -26 | -0.9% | 19,100 |
| 2025/06/02 | 2,949 | 2,978 | 2,948 | 2,964 | -29 | -1% | 17,600 |
| 2025/05/30 | 2,933 | 2,998 | 2,933 | 2,993 | +24 | +0.8% | 27,900 |
| 2025/05/29 | 2,947 | 2,981 | 2,947 | 2,969 | +29 | +1% | 22,000 |
| 2025/05/28 | 2,973 | 2,984 | 2,939 | 2,940 | -24 | -0.8% | 22,800 |
| 2025/05/27 | 2,945 | 2,973 | 2,941 | 2,964 | +3 | +0.1% | 10,900 |
| 2025/05/26 | 3,010 | 3,010 | 2,935 | 2,961 | -15 | -0.5% | 35,800 |
| 2025/05/23 | 2,956 | 2,993 | 2,941 | 2,976 | +54 | +1.8% | 32,600 |
| 2025/05/22 | 2,938 | 2,964 | 2,921 | 2,922 | -53 | -1.8% | 26,200 |
| 2025/05/21 | 2,959 | 2,998 | 2,959 | 2,975 | +37 | +1.3% | 19,600 |
| 2025/05/20 | 2,975 | 2,980 | 2,928 | 2,938 | -37 | -1.2% | 20,500 |
| 2025/05/19 | 2,960 | 3,005 | 2,952 | 2,975 | -4 | -0.1% | 17,000 |
| 2025/05/16 | 2,962 | 2,995 | 2,943 | 2,979 | ±0 | ±0% | 15,800 |
| 2025/05/15 | 2,991 | 3,040 | 2,974 | 2,979 | -31 | -1% | 22,700 |
| 2025/05/14 | 3,040 | 3,040 | 2,973 | 3,010 | -40 | -1.3% | 41,300 |
| 2025/05/13 | 3,120 | 3,195 | 3,040 | 3,050 | -45 | -1.5% | 30,900 |
| 2025/05/12 | 3,085 | 3,115 | 3,060 | 3,095 | ±0 | ±0% | 36,800 |
| 2025/05/09 | 3,045 | 3,115 | 3,040 | 3,095 | +45 | +1.5% | 27,300 |
| 2025/05/08 | 3,070 | 3,070 | 3,005 | 3,050 | -20 | -0.7% | 29,600 |
| 2025/05/07 | 3,070 | 3,080 | 3,050 | 3,070 | -20 | -0.6% | 28,100 |
| 2025/05/02 | 3,090 | 3,120 | 3,080 | 3,090 | +5 | +0.2% | 17,800 |
| 2025/05/01 | 3,070 | 3,100 | 3,050 | 3,085 | -5 | -0.2% | 16,300 |
| 2025/04/30 | 3,105 | 3,115 | 3,080 | 3,090 | -5 | -0.2% | 23,800 |
| 2025/04/28 | 3,115 | 3,120 | 3,060 | 3,095 | -10 | -0.3% | 73,700 |
| 2025/04/25 | 3,085 | 3,105 | 3,065 | 3,105 | -5 | -0.2% | 17,900 |
| 2025/04/24 | 3,135 | 3,135 | 3,090 | 3,110 | -30 | -1% | 15,200 |
| 2025/04/23 | 3,115 | 3,145 | 3,110 | 3,140 | +65 | +2.1% | 25,200 |
| 2025/04/22 | 3,045 | 3,110 | 3,045 | 3,075 | +30 | +1% | 17,600 |
| 2025/04/21 | 3,040 | 3,070 | 3,010 | 3,045 | -20 | -0.7% | 15,000 |
| 2025/04/18 | 2,979 | 3,065 | 2,949 | 3,065 | +123 | +4.2% | 17,200 |
| 2025/04/17 | 2,931 | 2,951 | 2,931 | 2,942 | -21 | -0.7% | 11,800 |
301~
350
件表示中 / 4031件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 328,000円 | +7.7% | +11.7% | 2.59% | 11.54倍 | 0.82倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 科研薬 | 396,500円 | +17.0% | - | 4.79% | 23.10倍 | 1.02倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
| ペプチド | 105,650円 | +72.8% | - | 0.00% | 45.29倍 | 2.80倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| ネクセラファーマ | 126,700円 | +39.5% | - | 0.00% | 21.05倍 | 1.79倍 |
|
創薬ベンチャー老舗。買収で成長。低分子で定評の英国創薬事業、日本の製造販売が事業2本柱 |
| ゼリア新薬 | 201,300円 | +6.6% | +17.7% | 2.48% | 8.87倍 | 0.82倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム